Grown Rogue International (GRUSF) Non-Current Debt (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Non-Current Debt came in at $9.9 million in Q1 2026, up 46.69% year-on-year from $6.8 million in Q1 2025, and down 1.03% quarter-over-quarter from $10.0 million in Q4 2025.

Grown Rogue International (GRUSF) Non-Current Debt (2009 - 2026) Analysis & Trends

Grown Rogue International's Non-Current Debt history runs 17 years deep, the most recent figure standing at $9.9 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 46.69% year-over-year to $9.9 million in Q1 2026; TTM through Mar 2026 was $9.9 million, a 46.69% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 383.07% from the prior year.
  • Non-Current Debt declined to $9.9 million in Q1 2026 per GRUSF's latest filing, from $10.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $10424.6 billion in Q3 2025 and bottomed at $60486.1 in Q4 2023.
  • The 5-year median for Non-Current Debt is $1.5 million (2024), against an average of $744.6 billion.
  • Across the five-year window, Non-Current Debt slumped 87.74% in 2023 and jumped 922180181.77% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $839222.0 in 2022, then tumbled by 92.79% to $60486.1 in 2023, then soared by 3329.07% to $2.1 million in 2024, then soared by 383.07% to $10.0 million in 2025, then decreased by 1.03% to $9.9 million in 2026.
  • Per Business Quant, the three latest GRUSF Non-Current Debt figures stand at $9.9 million (Q1 2026), $10.0 million (Q4 2025), and $10424.6 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 9.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.92 Mn
Dec 31, 2025 10.02 Mn
Sep 30, 2025 10,424.63 Bn
Jun 30, 2025 6.59 Mn
Mar 31, 2025 6.76 Mn
Dec 31, 2024 2.07 Mn
Sep 30, 2024 1.13 Mn
Jun 30, 2024 1.18 Mn
Mar 31, 2024 1.78 Mn
Dec 31, 2023 60,486.06
Oct 31, 2023 102,913.00
Apr 30, 2023 289,854.00
Jan 31, 2023 339,664.00
Oct 31, 2022 839,222.00
Oct 31, 2021 1.37 Mn
Apr 30, 2021 1.17 Mn
Jan 31, 2021 1.05 Mn
Oct 31, 2020 753,715.00
Jul 31, 2020 485,855.00
Apr 30, 2020 585,191.00